Summary of Study ST000876

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000607. The data can be accessed directly via it's Project DOI: 10.21228/M86Q34 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST000876
Study TitleHuman serum for a patient with neuropathy being treated with L-serine.
Study Typedrug dosage
Study SummaryOral serine dosing over 52 week study period
Institute
University of Helsinki
DepartmentMolecular Neurology
Last NameYlikallio
First NameEmil
AddressHartmaninkatu 8, 00290 Helsinki, Finland
Emailemil.ylikallio@helsinki.fi
PhoneNone
Submit Date2017-09-05
PublicationsClinical and metabolic consequences of L-serine supplementation in hereditary sensory and autonomic neuropathy type 1C, Cold Spring Harbor Molecular Case Studies
Analysis Type DetailLC-MS
Release Date2017-10-11
Release Version1
Emil Ylikallio Emil Ylikallio
https://dx.doi.org/10.21228/M86Q34
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN001413
Analysis type MS
Chromatography type None (Direct infusion)
Chromatography system None
Column none
MS Type ESI
MS instrument type Triple quadrupole
MS instrument name Waters Xevo-TQ-S
Ion Mode POSITIVE
Units ┬ÁM

MS:

MS ID:MS001304
Analysis ID:AN001413
Instrument Name:Waters Xevo-TQ-S
Instrument Type:Triple quadrupole
MS Type:ESI
Ion Mode:POSITIVE
  logo